Cross-source identity
National Provider Identifier 1144228388 as it appears in every federal dataset Fonteum holds. Each row is a distinct public source; the chip carries the source and the snapshot date behind that field — the record-level form of the source-provenanced graph.
| Federal source | Key | What it provides | Provenance |
|---|
| CMS NPPES | NPI 1144228388 | Registry identity — dermatologist, taxonomy 207N00000X | Source:CMS NPPESSnapshot 2026-05-06 |
| CMS Open Payments | NPI 1144228388 | 47 industry-payment records, 2024 | Source:CMS Open PaymentsSnapshot PY2024 |
| CMS Medicare Part D | NPI 1144228388 | 23 drugs prescribed, 2024 | Source:CMS Part DSnapshot DY2024 |
Industry payments
Payments and transfers of value this clinician received from drug and device manufacturers, disclosed under the Physician Payments Sunshine Act. A payment is a disclosure, not a judgment.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $933 | 47 |
| Manufacturer | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $245 | 17 |
| Novartis Pharmaceuticals Corporation | $200 | 9 |
| Genzyme Corporation | $85 |
Prescribing
Prescriptions written under Medicare Part D, aggregated by drug across the program. Totals reflect claims paid, not patients treated.
| Drug | Claims | Drug cost |
|---|---|---|
| Dupixent Pen(Dupilumab) | 70 | $257,639 |
| Otezla(Apremilast) | 22 | $104,705 |
| Clobetasol Propionate | 121 | $7,267 |
| Fluocinonide | 160 | $6,013 |
| Ketoconazole | 234 | $4,149 |
Beneficiary counts below 11 are suppressed by CMS — the total shown is a lower bound.
Quality
CMS Quality Payment Program Merit-based Incentive Payment System (MIPS) final score, where this clinician participated. Absence of a score is not a quality signal — many clinicians report through a group or are exempt.
Enrollment & sanctions
Screening aid — re-confirm any match against the issuing list before acting. A clean result means no record was found in the federal OIG LEIE or the state Medicaid lists Fonteum currently holds (NY, OH, GA), not a guarantee that none exists elsewhere. Not a legal or credentialing certification.
| 2 |
| Abbvie Inc. | $71 | 4 |
| Amgen Inc. | $66 | 3 |